Korean Circ J.  2023 Apr;53(4):251-253. 10.4070/kcj.2023.0031.

Can Artemisinin Be a Game Changer Even as an Antiarrhythmic Drug?

• Hwang J

• KMID: 2542295
• DOI: http://doi.org/10.4070/kcj.2023.0031

Reference

1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022; 43:3997–4126. PMID: 36017572.

2. Talib AK, Nogami A. Catheter ablation for Brugada syndrome. Korean Circ J. 2020; 50:289–301. PMID: 31960637.

3. Campbell T, Bennett RG, Kotake Y, Kumar S. Updates in ventricular tachycardia ablation. Korean Circ J. 2021; 51:15–42. PMID: 33377327.

4. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011; 17:1217–1220. PMID: 21989013.

5. Wang J, Xu C, Wong YK, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering (Beijing). 2019; 5:32–39.

6. Jang S, Jeong MH, Lim KS, et al. Effect of stents coated with artemisinin or dihydroartemisinin in a porcine coronary restenosis model. Korean Circ J. 2017; 47:115–122. PMID: 28154599.

7. Jeong HK, Hong SN, Yoon N, Lee KH, Park HW, Cho JG. Antiarrhythmic effect of artemisinin in an ex-vivo model of Brugada syndrome induced by NS5806. Korean Circ J. 2023; 53:239–250. PMID: 37161682.

8. Saadeh K, Nantha Kumar N, Fazmin IT, Edling CE, Jeevaratnam K. Anti-malarial drugs: mechanisms underlying their proarrhythmic effects. Br J Pharmacol. 2022; 179:5237–5258. PMID: 36165125.

9. Kim D, Yang PS, Joung B. Optimal rhythm control strategy in patients with atrial fibrillation. Korean Circ J. 2022; 52:496–512. PMID: 35790494.